\BOOKMARK [0][-]{section*.2}{List of Abbreviations}{}% 1
\BOOKMARK [0][-]{table.0.1}{List of Figures}{}% 2
\BOOKMARK [0][-]{section*.5}{List of Tables}{}% 3
\BOOKMARK [0][-]{chapter.1}{An Introduction to the Physical Biology}{}% 4
\BOOKMARK [1][-]{section.1.1}{Thesis and Chapter Summary}{chapter.1}% 5
\BOOKMARK [1][-]{section.1.2}{What is Physics?}{chapter.1}% 6
\BOOKMARK [1][-]{section.1.3}{The Physics Inside your Cells}{chapter.1}% 7
\BOOKMARK [1][-]{section.1.4}{Using Ion Channels as Natural Laboratories to Learn Biophysics}{chapter.1}% 8
\BOOKMARK [1][-]{section.1.5}{Studying Cystic Fibrosis; Toward a Molecular Theory of Disease.}{chapter.1}% 9
\BOOKMARK [1][-]{section.1.6}{The Future is Biological}{chapter.1}% 10
\BOOKMARK [0][-]{chapter.2}{From Protons to Proteins: Methods to simulate the inside of a cell.}{}% 11
\BOOKMARK [1][-]{section.2.1}{Quantum Mechanics is Not Tractable at the Scale of Biology.}{chapter.2}% 12
\BOOKMARK [2][-]{subsection.2.1.1}{A full quantum mechanical treatment}{section.2.1}% 13
\BOOKMARK [2][-]{subsection.2.1.2}{The Born-Oppenheimer approximation.}{section.2.1}% 14
\BOOKMARK [1][-]{section.2.2}{Classical MD; Molecular Motions Without Quantum Mechanics}{chapter.2}% 15
\BOOKMARK [2][-]{subsection.2.2.1}{Philosophy of Different Molecular Mechanics forcefields.}{section.2.2}% 16
\BOOKMARK [1][-]{section.2.3}{Periodic Boundaries to Simulate the Inside of a Cell}{chapter.2}% 17
\BOOKMARK [1][-]{section.2.4}{Controlling the Temperature and Pressure in a Simulation}{chapter.2}% 18
\BOOKMARK [2][-]{subsection.2.4.1}{Hot and Cold with the Nos\351-Hoover Thermostat}{section.2.4}% 19
\BOOKMARK [2][-]{subsection.2.4.2}{Under Pressure with the Parinello-Rahman Barostat}{section.2.4}% 20
\BOOKMARK [1][-]{section.2.5}{The Process of Preparing an MD Simulation}{chapter.2}% 21
\BOOKMARK [1][-]{section.2.6}{Choosing an Appropriate Time Step}{chapter.2}% 22
\BOOKMARK [2][-]{subsection.2.6.1}{ Verlet Leap-Frog Integration}{section.2.6}% 23
\BOOKMARK [1][-]{section.2.7}{Free Energy Calculations: Making Simulations More Useful}{chapter.2}% 24
\BOOKMARK [2][-]{subsection.2.7.1}{Umbrella Sampling}{section.2.7}% 25
\BOOKMARK [2][-]{subsection.2.7.2}{Metadynamics}{section.2.7}% 26
\BOOKMARK [1][-]{section.2.8}{Short Comings of Classical MD}{chapter.2}% 27
\BOOKMARK [2][-]{subsection.2.8.1}{The Problem with Forcefields}{section.2.8}% 28
\BOOKMARK [2][-]{subsection.2.8.2}{The Problem with Sampling}{section.2.8}% 29
\BOOKMARK [1][-]{section.2.9}{Conclusion}{chapter.2}% 30
\BOOKMARK [0][-]{chapter.3}{Review of the Molecular Cause of Cystic Fibrosis and Its Treatment}{}% 31
\BOOKMARK [1][-]{section.3.1}{Clinical outcomes of Cystic Fibrosis}{chapter.3}% 32
\BOOKMARK [1][-]{section.3.2}{CFTR Structure}{chapter.3}% 33
\BOOKMARK [1][-]{section.3.3}{CFTR is a Unique ABC Transporter}{chapter.3}% 34
\BOOKMARK [1][-]{section.3.4}{The Misfunction of CFTR causes CF}{chapter.3}% 35
\BOOKMARK [2][-]{subsection.3.4.1}{The Gating Cycle}{section.3.4}% 36
\BOOKMARK [2][-]{subsection.3.4.2}{Anion Selectivity}{section.3.4}% 37
\BOOKMARK [1][-]{section.3.5}{Classes of Mutation Which Cause Cystic Fibrosis}{chapter.3}% 38
\BOOKMARK [1][-]{section.3.6}{CFTR Modulators}{chapter.3}% 39
\BOOKMARK [2][-]{subsection.3.6.1}{Correctors}{section.3.6}% 40
\BOOKMARK [2][-]{subsection.3.6.2}{Potentiators}{section.3.6}% 41
\BOOKMARK [2][-]{subsection.3.6.3}{Patients with rare mutations struggle to gain access to modulator therapy}{section.3.6}% 42
\BOOKMARK [1][-]{section.3.7}{Patient Derived Organoids as a Pre Clinical Model}{chapter.3}% 43
\BOOKMARK [2][-]{subsection.3.7.1}{Forskolin Induced Swelling}{section.3.7}% 44
\BOOKMARK [2][-]{subsection.3.7.2}{Cilia Beating Frequency}{section.3.7}% 45
\BOOKMARK [2][-]{subsection.3.7.3}{Electrophysiology}{section.3.7}% 46
\BOOKMARK [2][-]{subsection.3.7.4}{Western Blotting to Assess CFTR Trafficking}{section.3.7}% 47
\BOOKMARK [0][-]{chapter.4}{Molecular Dynamics and Functional Characterization of I37R-CFTR Lasso Mutation Provide Insights into Channel Gating Activity}{}% 48
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 49
\BOOKMARK [1][-]{section.4.2}{Results}{chapter.4}% 50
\BOOKMARK [2][-]{subsection.4.2.1}{I37R-CFTR Baseline Activity in Patient-Derived Rectal Biopsies and Intestinal Organoids}{section.4.2}% 51
\BOOKMARK [2][-]{subsection.4.2.2}{I37R-CFTR Functional Response to CFTR Modulator Monotherapy in Intestinal Organoids}{section.4.2}% 52
\BOOKMARK [2][-]{subsection.4.2.3}{I37R-CFTR Perturbs the Noose Structure of the Lasso Motif}{section.4.2}% 53
\BOOKMARK [2][-]{subsection.4.2.4}{I37R Mutation Strengthens Lasso Motif Interaction with the R-domain}{section.4.2}% 54
\BOOKMARK [1][-]{section.4.3}{Discussion}{chapter.4}% 55
\BOOKMARK [1][-]{section.4.4}{Method Details}{chapter.4}% 56
\BOOKMARK [1][-]{section.4.5}{Acknowledgements}{chapter.4}% 57
\BOOKMARK [1][-]{section.4.6}{Author Contributions}{chapter.4}% 58
\BOOKMARK [1][-]{section.4.7}{Delcaration of Interests}{chapter.4}% 59
\BOOKMARK [0][-]{chapter.5}{Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect}{}% 60
\BOOKMARK [0][-]{chapter.6}{Unique S945L-CFTR defect Restored by CFTR Modulator Co-Therapy In Vitro Correlates with In Vivo Biomarkers Post-Therapy}{}% 61
\BOOKMARK [1][-]{section.6.1}{Introduction}{chapter.6}% 62
\BOOKMARK [0][-]{chapter.7}{Resolving a Conducting Conformation of CFTR Using Free Energy Calculations}{}% 63
\BOOKMARK [1][-]{section.7.1}{Introduction}{chapter.7}% 64
\BOOKMARK [1][-]{section.7.2}{Results}{chapter.7}% 65
\BOOKMARK [2][-]{subsection.7.2.1}{The outer pore in the CryoEM structure of phosphorylated human CFTR is not sufficiently open to conduct anions}{section.7.2}% 66
\BOOKMARK [2][-]{subsection.7.2.2}{Using metadynamics and long simulations we can dilate the pore to discover a conducting conformation}{section.7.2}% 67
\BOOKMARK [2][-]{subsection.7.2.3}{Proving the discovered conformation is capable of ion conduction with umbrella sampling}{section.7.2}% 68
\BOOKMARK [2][-]{subsection.7.2.4}{This open conformation gives rise to a novel salt bridge}{section.7.2}% 69
\BOOKMARK [2][-]{subsection.7.2.5}{This open state can be used to study disease causing mutations such as R334W in the outer pore}{section.7.2}% 70
\BOOKMARK [1][-]{section.7.3}{Discussion}{chapter.7}% 71
\BOOKMARK [1][-]{section.7.4}{Conclusion}{chapter.7}% 72
\BOOKMARK [1][-]{section.7.5}{Methods Details}{chapter.7}% 73
\BOOKMARK [0][-]{chapter.8}{Concluding Remarks: Where next for Molecular Studies of CFTR.}{}% 74
\BOOKMARK [1][-]{section.8.1}{Addressing Controversies Surrounding the Structure of CFTR}{chapter.8}% 75
\BOOKMARK [1][-]{section.8.2}{A Physics Motivated Model for the Molecular Modulation of Mutant CFTR }{chapter.8}% 76
\BOOKMARK [1][-]{section.8.3}{A Physics Motivated Approach to Precision Medicine in Cystic Fibrosis}{chapter.8}% 77
\BOOKMARK [1][-]{section.8.4}{Outstanding fundamental questions about CFTR Function}{chapter.8}% 78
\BOOKMARK [1][-]{section.8.5}{Grouping of Theratypes}{chapter.8}% 79
\BOOKMARK [1][-]{section.8.6}{Resolving Drug Action}{chapter.8}% 80
\BOOKMARK [0][-]{appendix*.43}{Bibliography}{}% 81
